Taylor Wessing advises First Cambridge Gateway on a £3.2m financing round of DanioLabs

26-Jan-2005  |  Corporate, Intellectual Property, Life Sciences & Healthcare, Technology

Taylor Wessing advised First Cambridge Gateway Fund on a £3.2m financing round of DanioLabs, the Cambridge-based biotechnology company.

Taylor Wessing advised First Cambridge Gateway Fund on a £3.2m financing round of DanioLabs, the Cambridge-based biotechnology company. The funding will be invested in the further discovery and development of new therapeutics and in developing a greater platform of sophisticated disease models to expand available screening services on an international basis. 

Corporate partner, Simon Walker, commented:

"We have an established relationship with First Cambridge Gateway and we are delighted to have advised on this investment."

The Taylor Wessing team advising First Cambridge Gateway Fund was led by Simon Walker, assisted by Kellie McCormack (Corporate) and Malcolm Bates and Darren Bezzina (both IP/Life Sciences).

DanioLabs was advised by Eversheds, while Hewitsons advised the existing shareholders.